Oncotype DX colon cancer assay

A 12 gene prognostic assay that measures gene expression in formalin-fixed paraffin-embedded colon cancer tissue by quantitative reverse transcription-polymerase chain reaction and generates a recurrence score that provides an estimate of the risk of recurrence.

The gene prognostic assay has been validated by 4 large studies.

Leave a Reply

Your email address will not be published. Required fields are marked *